Insmed
INSM
#965
Rank
โ‚น2.392 T
Marketcap
โ‚น10,904
Share price
1.48%
Change (1 day)
-35.92%
Change (1 year)

Earnings for Insmed (INSM)

Earnings in 2026 (TTM): -โ‚น47.88 Billion

According to Insmed's latest financial reports the company's current earnings are โ‚น1.51 Billion. In 2025 the company made an earning of -โ‚น112.16 Billion a decrease over its 2024 earnings that were of -โ‚น77.94 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insmed from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น47.88 Billion-57.32%
2025 -โ‚น112.16 Billion43.91%
2024 -โ‚น77.94 Billion23.71%
2023 -โ‚น63 Billion45.77%
2022 -โ‚น43.22 Billion15.83%
2021 -โ‚น37.32 Billion50.19%
2020 -โ‚น24.85 Billion16.4%
2019 -โ‚น21.35 Billion-23.9%
2018 -โ‚น28.05 Billion59.35%
2017 -โ‚น17.6 Billion8.52%
2016 -โ‚น16.22 Billion47.25%
2015 -โ‚น11.02 Billion34.53%
2014 -โ‚น8.19 Billion58.83%
2013 -โ‚น5.16 Billion35.14%
2012 -โ‚น3.82 Billion-31.92%
2011 -โ‚น5.61 Billion854.92%
2010 -โ‚น0.59 Billion-105.22%
2009 โ‚น11.23 B-905.06%
2008 -โ‚น1.4 Billion-27.31%
2007 -โ‚น1.92 Billion-62.41%
2006 -โ‚น5.11 Billion98.19%
2005 -โ‚น2.58 Billion0.03%
2004 -โ‚น2.58 Billion159.07%
2003 -โ‚น1 Billion-69.31%
2002 -โ‚น3.24 Billion
2000 -โ‚น2.93 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
โ‚น1.187 T-2,520.36%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Gilead Sciences
GILD
-โ‚น183.61 Billion 274.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
โ‚น473.71 B-1,065.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
-โ‚น12.3 Billion-74.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-โ‚น2.19 Billion-95.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
-โ‚น4.86 Billion-90.11%๐Ÿ‡บ๐Ÿ‡ธ USA